Datavault AI (NASDAQ: DVLT) announced an expansion of its definitive licensing agreement with DataMeds AI Inc., extending the PharmacyChain blockchain technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement aims to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the amended terms, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization. This move accelerates the deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
The expanded relationship is significant as it positions Datavault AI to capitalize on the growing intersection of blockchain, AI, and healthcare data management. By allowing patients to control and monetize their own health data, the technology addresses key privacy and ownership concerns, potentially disrupting traditional data silos in healthcare. The integration with wearable devices and remote monitoring also aligns with the shift toward personalized medicine and preventive health.
Datavault AI’s platform combines its Acoustic Sciences division, featuring WiSA, ADIO, and Sumerian patented technologies for wireless high-definition audio, with its Data Science division that leverages Web 3.0 and high-performance computing for data valuation and secure monetization. The Information Data Exchange enables Digital Twins and secure attachment of physical objects to immutable metadata, fostering responsible AI.
For more details, the full press release is available at https://ibn.fm/vBAxH. Forward-looking statements involve risks and uncertainties as detailed in the company's SEC filings. The latest updates on DVLT can be found at https://ibn.fm/DVLT.
